SEMAGLUTIDE : ONE COMPARATIVE REVIEW

The emerging class of GLP-1 receptor and GIP co-agonist medications, like tirzepatide, semaglutide, and the newly introduced retatrutide, provide significant progress in metabolic control. While all three operate by modulating blood levels , they distinguish in their unique mechanisms of action .